In This Article:
As we navigate the Canadian market landscape in 2025, investors are contending with rising government bond yields and political shifts that have introduced a layer of uncertainty. Despite these challenges, maintaining a diversified portfolio remains crucial, particularly as opportunities arise to invest in overlooked small-cap stocks that offer potential growth and value. Identifying good stocks often involves looking for those with solid fundamentals and the ability to thrive amid economic fluctuations, making them valuable additions to any portfolio seeking resilience and growth.
Top 10 Undiscovered Gems With Strong Fundamentals In Canada
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Reconnaissance Energy Africa | NA | 9.16% | 15.11% | ★★★★★★ |
Minsud Resources | NA | nan | -29.01% | ★★★★★★ |
Amerigo Resources | 14.04% | 7.04% | 11.73% | ★★★★★☆ |
Maxim Power | 25.01% | 12.79% | 17.14% | ★★★★★☆ |
Mako Mining | 10.21% | 38.44% | 58.78% | ★★★★★☆ |
Grown Rogue International | 24.92% | 19.37% | 188.55% | ★★★★★☆ |
Corby Spirit and Wine | 65.79% | 7.46% | -5.76% | ★★★★☆☆ |
Petrus Resources | 19.44% | 17.20% | 46.03% | ★★★★☆☆ |
Genesis Land Development | 47.40% | 28.61% | 52.30% | ★★★★☆☆ |
DIRTT Environmental Solutions | 58.73% | -5.34% | -5.43% | ★★★★☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Extendicare
Simply Wall St Value Rating: ★★★★☆☆
Overview: Extendicare Inc., with a market cap of approximately CA$860.54 million, operates through its subsidiaries to provide care and services for seniors in Canada.
Operations: Extendicare generates revenue primarily from Long-Term Care (CA$808.94 million) and Home Health Care (CA$545.46 million), with additional income from Managed Services (CA$70.43 million).
Extendicare, a smaller player in the healthcare sector, has shown impressive financial strides recently. Its debt-to-equity ratio decreased from 412.5% to 244.3% over five years, indicating improved financial management. The company’s interest payments are well-covered by EBIT at 8.4 times, showcasing robust earnings quality. Notably, earnings surged by 261%, outpacing the healthcare industry's growth of 11%. With a price-to-earnings ratio of 13.5x below the Canadian market average of 14.2x, it presents an attractive valuation for investors seeking value in under-the-radar stocks in Canada’s healthcare landscape.
-
Delve into the full analysis health report here for a deeper understanding of Extendicare.
-
Examine Extendicare's past performance report to understand how it has performed in the past.
High Liner Foods
Simply Wall St Value Rating: ★★★★★☆